エピソード

  • Episode 11- Talking about a revolution: Science Communication & In Silico Medicine
    2025/04/30
    In 2013, Sir Mark Walport, then Chief Scientific Adviser to the UK government, famously said, "Science is not finished until it is communicated." He urged climate change experts to make their work accessible to wider audiences — a message that rings even truer today, especially for the field of in silico medicine. As these technologies move closer to patients' lives, clear and effective communication will be essential to build trust and understanding.

    To celebrate one year of The Digital Twin Theory podcast, this special episode flips the script: host Davide Montesarchio becomes the guest, interviewed by our manager, Martina Contin, to explore why — and how — we must communicate in silico medicine to the world.
    続きを読む 一部表示
    26 分
  • Episode 10- Beating Bits: AI helping cardiology
    2025/03/31
    Let’s delve into the clinical applications of in silico medicine! Our guest for this episode is Dr. Elisa Rauseo, cardiologist and Clinical Research Fellow in Cardiovascular Digital Twins at the Queen Mary University of London. Together, we will discuss the applications of AI and machine learning in cardiology and also how ready medical doctors are to apply in silico tools in their practice.
    続きを読む 一部表示
    19 分
  • Episode 9- Bones, Joints, and Bytes
    2025/02/27
    Musculoskeletal applications are among the most advanced frontiers of in silico medicine. In our first episode of 2025, we sit down with a true pioneer in the field—Prof. Marco Viceconti.

    From the early days, when only a handful of visionaries foresaw a future where medicine was driven by data and computational models, to the present, Marco has been a driving force in this revolution.

    His contributions are remarkable: he founded and directed the Medical Technology Lab at the Istituto Ortopedico Rizzoli, established and led the Insigneo Institute for In Silico Medicine, and served as the first Executive Director of VPHi.

    Join us as we explore the evolution of in silico medicine through the insights of one of its most influential figures.
    続きを読む 一部表示
    31 分
  • Episode 8- Simulating the beat: How in silico medicine is changing cardiology
    2024/12/17
    In silico medicine is transforming healthcare, and some of its most groundbreaking applications are happening in cardiology. In our final episode of 2024, we explore how this innovative technology is reshaping the future of heart health.

    Joining us is Mariano Vazquez, CTO and CSO of ELEM Biotech—a spinoff of the Barcelona Supercomputing Center (BSC)—where he also leads cutting-edge research.
    続きを読む 一部表示
    13 分
  • Episode 7- Code & Care: Society's Role in Shaping In Silico Medicine
    2024/11/27
    In this episode, we will discuss about social implications and trust in in silico medicine with our guest Zita van Horenbeeck, social scientist at the Virtual Physiological Human Institute and PhD student at the Life Sciences and Society Lab of KU Leuven.
    続きを読む 一部表示
    16 分
  • Episode 6- Ethics and the Virtual Human Twin
    2024/11/05
    In silico medicine, as a breakthrough in technology and healthcare, carries a series of ethical issues, including managing personal health data, the technological divide, and the doctor-patient relationship.


    To explore this topic, we interviewed Michele Barbier, an independent ethics expert for the European Commission and EU project coordinator at INRIA working on digital twins. Her insights offer a closer look at this transformative field's challenges and promises.
    続きを読む 一部表示
    12 分
  • Episode 5- Protecting privacy in the age of data
    2024/09/26
    Without data, in silico medicine wouldn't even be possible. In this episode we will explore how data, especially medical data, needs to be managed to make in silico medicine a reality.

    Our guest for this episode is Elisabetta Biasin, doctoral researcher at the Centre for IT and IP Law at KU Leuven.
    続きを読む 一部表示
    14 分
  • Episode 4- Virtual Patients: Exploring the world of in silico trials
    2024/06/28
    Do you know how long it takes for a drug to reach the pharmacy?

    Drug development, testing, and approval take 10 to 15 years and cost millions of euros. Most of this time and money go into clinical trials, which are essential for proving the drug's safety and effectiveness.

    Clinical trials are crucial, but can we make this process faster, cheaper, and safer for both animals and humans? The short answer is yes. For the longer answer, we turn to the guest of this episode, Francesco Pappalardo, Professor of Computer Science at the University of Catania.
    続きを読む 一部表示
    15 分